Amyloidosis trials in Austria
3 of 10 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in AustriaSingle-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor
- Where
- Innsbruck
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Bayer
See details and how to joinNCT07557147 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462 - No phaseTaking peopleA Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
- Where
- Graz, Vienna
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT06836011